Targeted first-line therapies for advanced colorectal cancer: a Bayesian meta-analysis

BACKGROUND: Colorectal cancer is common and deadly. First-line treatments for patients with metastatic disease include FOLFIRI and FOLFOX, which have been combined with anti-EGFR or anti-VEGF antibodies to achieve benefit in selected populations. However, optimal therapy remains unclear. RESULTS: Fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ridouane, Yassine, Lopes, Gilberto, Ku, Geoffrey, Masud, Hasan, Haaland, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630427/
https://www.ncbi.nlm.nih.gov/pubmed/29029527
http://dx.doi.org/10.18632/oncotarget.20185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630427/
https://www.ncbi.nlm.nih.gov/pubmed/29029527
http://dx.doi.org/10.18632/oncotarget.20185

Ejemplares similares